PYHIN1
Basic information
Region (hg38): 1:158930796-158977059
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PYHIN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 4 | 1 |
Variants in PYHIN1
This is a list of pathogenic ClinVar variants found in the PYHIN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-158936955-G-C | not specified | Uncertain significance (Sep 27, 2024) | ||
1-158936989-T-A | not specified | Uncertain significance (Dec 07, 2024) | ||
1-158937019-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
1-158937148-G-A | not specified | Likely benign (Jul 09, 2024) | ||
1-158938466-T-A | not specified | Uncertain significance (Oct 29, 2024) | ||
1-158938480-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
1-158938501-C-G | not specified | Uncertain significance (Sep 26, 2023) | ||
1-158938525-G-A | not specified | Uncertain significance (Aug 28, 2024) | ||
1-158939091-A-C | not specified | Uncertain significance (Dec 28, 2023) | ||
1-158939174-C-T | not specified | Likely benign (Apr 28, 2022) | ||
1-158939189-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
1-158939192-G-T | not specified | Uncertain significance (Oct 13, 2021) | ||
1-158939201-C-G | not specified | Uncertain significance (Nov 14, 2024) | ||
1-158939215-T-C | not specified | Uncertain significance (Sep 15, 2021) | ||
1-158941978-G-A | not specified | Likely benign (Jan 27, 2022) | ||
1-158941999-G-A | Malignant tumor of prostate | Uncertain significance (-) | ||
1-158942007-A-G | not specified | Likely benign (Sep 09, 2024) | ||
1-158942011-C-T | not specified | Uncertain significance (Jul 30, 2024) | ||
1-158942029-G-A | not specified | Uncertain significance (Jun 23, 2021) | ||
1-158942046-G-A | not specified | Uncertain significance (Mar 30, 2022) | ||
1-158942074-T-C | not specified | Uncertain significance (Nov 10, 2024) | ||
1-158942125-T-C | not specified | Uncertain significance (Jun 16, 2023) | ||
1-158942196-A-G | not specified | Uncertain significance (Mar 24, 2023) | ||
1-158942198-A-T | not specified | Uncertain significance (Jul 06, 2021) | ||
1-158942204-C-G | not specified | Uncertain significance (Oct 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PYHIN1 | protein_coding | protein_coding | ENST00000368140 | 7 | 46259 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.78e-10 | 0.268 | 125740 | 0 | 7 | 125747 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.135 | 270 | 264 | 1.02 | 0.0000137 | 3220 |
Missense in Polyphen | 64 | 66.255 | 0.96596 | 917 | ||
Synonymous | 1.28 | 77 | 92.7 | 0.831 | 0.00000481 | 954 |
Loss of Function | 0.742 | 16 | 19.5 | 0.819 | 0.00000104 | 271 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000670 | 0.0000670 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000449 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Major mediator of the tumor suppressor activity of IFN in breast cancer cells. Promotes ubiquitination and subsequent degradation of MDM2, which leads to p53/TP53 stabilization. Promotes ubiquitination and subsequent degradation of HDAC1, which in turn enhances maspin expression, and impairs invasive activity of cancer cells. {ECO:0000269|PubMed:16479015, ECO:0000269|PubMed:18247378}.;
Recessive Scores
- pRec
- 0.0614
Intolerance Scores
- loftool
- 0.989
- rvis_EVS
- 0.0000761
- rvis_percentile_EVS
- 53.98
Haploinsufficiency Scores
- pHI
- 0.0365
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.425
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.705
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- activation of innate immune response;cell cycle;protein destabilization;cellular response to interferon-alpha;cellular response to interferon-beta;positive regulation of DNA binding;positive regulation of transcription, DNA-templated;protein stabilization;positive regulation of protein localization to nucleus;positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of ubiquitin-dependent protein catabolic process
- Cellular component
- nuclear speck;protein-containing complex
- Molecular function
- ubiquitin protein ligase binding